Evidence map›Paper›PMID 29259694›Full record

ArticleInflammation and regeneration2016

Atsuko Masumi, Keiko Mochida, Kazuya Takizawa, Takuo Mizukami, Madoka Kuramitsu, Momoka Tsuruhara, Shigetarou Mori, Keigo Shibayama, Kazunari Yamaguchi, Isao Hamaguchi

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Inflammation and regeneration, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 90% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Atsuko MasumiDepartment of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, Tokyo, Japan.
Keiko MochidaDepartment of Bacteriology II, National Institute of Infectious Diseases, 4-7-1, Gakuen Musashimurayama-shi, Tokyo, 208-0011 Japan.
Kazuya TakizawaDepartment of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, Tokyo, Japan.
Takuo MizukamiDepartment of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, Tokyo, Japan.
Madoka KuramitsuDepartment of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, Tokyo, Japan.
Momoka TsuruharaDepartment of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, Tokyo, Japan.
Shigetarou MoriDepartment of Bacteriology II, National Institute of Infectious Diseases, 4-7-1, Gakuen Musashimurayama-shi, Tokyo, 208-0011 Japan.
Keigo ShibayamaDepartment of Bacteriology II, National Institute of Infectious Diseases, 4-7-1, Gakuen Musashimurayama-shi, Tokyo, 208-0011 Japan.
Kazunari YamaguchiDepartment of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, Tokyo, Japan.
Isao HamaguchiDepartment of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, Tokyo, Japan.
National Institute of Infectious Diseases · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBacterial infections cause an increase in the population of hematopoietic stem cells (HSCs). To investigate the downstream factors associated with hematopoietic stem cells, mice are infected with

results

conclusionsThis finding suggests that the IFN-γ production mediated by

Indexed as

Bone marrowHematopoietic stem cellsIFN-γInfectionInterferon regulatory factorMycobacterium aviumSpleen

Identifiers

PMID29259694
PMCPMC5725973
OpenAlexW2512536576

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.